What are you searching for…

Baker Ruskinn co-sponsored the Nantes Oct ’16 conference focused on “the role of hypoxia under physiological conditions as well as in cancer”.

Baker Ruskinn co-sponsored the Nantes Oct ’16 conference focused on “the role of hypoxia under physiological conditions as well as in cancer”.


The main objective of this conference was to bring together a large group of scientists from different spheres of hypoxia. Download the paper: ‘Update on hypoxia-inducible factors and hydroxylases in oxygen regulatory pathways: from physiology to therapeautics’ to review recent advances in: genomics, physiology, musculoskeletal, stem cells, microenvironment and cancer, and oxidative stress.

View Baker’s solutions designed for Hypoxia including our Invivo2 Physiological Cell Culture Workstations.